Clinical Trial Update: Clinical Study of a Novel Humanized CD70-Targeted CAR-T Cell Incorporating TLR2 for Advanced Renal Cell Carcinoma Therapy [EARLY_Phase 1]

View source ↗

Summary

An early-phase study evaluating a novel humanized CD70-targeted CAR-T cell therapy incorporating TLR2 for advanced renal cell carcinoma; recruitment not yet sta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• CD70-targeted CAR-T cell therapy incorporating TLR2 (CD70-targeted CAR-T cell therapy incorporating TLR2)

Snippet

Sponsor: Wei Guan | Conditions: Advanced Renal Cell Carcinoma | EARLY_Phase 1 | Status: NOT_YET_RECRUITING